Cell Therapy Human Raw Materials Industry Valued at $7.05 Billion by 2029 With CAGR of 20.1% | Size and Share Insights
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Cell Therapy Human Raw Materials Market From 2025 To 2029?
In recent times, the market size for human raw materials in cell therapy has experienced significant expansion. The market is predicted to increase from $2.82 billion in 2024 to $3.39 billion in 2025, boasting a compound annual growth rate (CAGR) of 20.4%. Contributing factors to such growth in the historic period include a heightened incidence of chronic illnesses, an escalating aging population, an increased need for regenerative medicines, state-backed funding and support, as well as skyrocketing healthcare costs.
What Is the Projected Market Size of the Cell Therapy Human Raw Materials Market?
The market size of the raw materials for human cell therapy is predicted to experience dramatic growth in the coming years. It’s expected to reach $7.05 billion by 2029 with a compound annual growth rate (CAGR) of 20.1%. The projected growth within this period can be attributed to the broadening therapeutic applications, heightened patient awareness, favorable regulatory conditions, expansion in the biopharmaceutical industry, and enhancement of manufacturing processes. The forecast period is also expected to see significant trends like the uptake of allogeneic therapies, the incorporation of artificial intelligence, the rise in available off-the-shelf cell therapies, the application of 3D bioprinting technology, and the progression of hybrid cell therapies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15759&type=smp
Who are the Major Competitors in the Cell Therapy Human Raw Materials Market Outlook?
Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Corning Incorporated, Lonza Group Ltd., Grifols S.A., WuXi AppTec, Catalent Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Pall Corporation, Bio-Techne Corporation, Miltenyi Biotec, Actylis, STEMCELL Technologies, Takara Bio Inc., Vericel Corporation, ACROBiosystems, BioIVT LLC, Orgenesis Inc., PromoCell GMBH, ViaCyte Inc., AllCells LLC, Sartorius CellGenix GmbH, Fujifilm Cellular Dynamics Inc., Mesoblast Limited, RoosterBio Inc., Thermogenesis Holdings Inc.
What Is Fueling Growth in the Cell Therapy Human Raw Materials Market?
The growing embracement of regenerative medicine is anticipated to propel the market for cell therapy human raw materials. Regenerative medicine, which leverages either the body’s innate regenerative capabilities or external stimuli like stem cells, tissue engineering, or gene therapy, focuses on restoring, renewing, or growing new tissues and organs to regain normal functionality. This concept is gaining popularity due to the progress in biotechnology, a heightened comprehension of cellular mechanisms, an increasing interest in personalized medicine, and the capability to adequately cater to unsatisfied medical requirements. Cell therapy and human raw materials are instrumental in promoting regenerative medicine as they provide vital biological ingredients required for cell-based therapies, leading to the creation of standardized and trustworthy treatments for various health problems. To illustrate, in August 2023, a report by the Alliance for Regenerative Medicine, a non-profit entity based in the US, revealed that there were 2760 cell, gene, and tissue-engineering therapy developers globally in Q1 2023, a rise of 101% from 1369 in Q1 2022. Thus, the escalating embrace of regenerative medicine is fueling the cell therapy human raw materials market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15759&type=smp
Which Cell Therapy Human Raw Materials Market Segments Are Growing the Fastest?
The cell therapy human raw materials market covered in this report is segmented –
1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials
2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy
3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions
Subsegments:
1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)
2) By Cell Culture Sera: Fetal Bovine Serum (FBS), Human Serum, Adult Bovine Serum
3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides
4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants
5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP), Vials And Storage Containers
Which Industry Trends Are Shaping the Future of the Cell Therapy Human Raw Materials Market?
In an effort to expedite the advancement of cell therapy, key players in the cell therapy human raw materials market are striving to create chemically structured cell culture mediums. These mediums are nutrient-dense solutions designed to supply vital nutrients, growth elements, and the required environmental conditions for cell growth and propagation beyond their natural surroundings. For instance, TheraPEAK T-VIVO Cell Culture Medium was launched in May 2023 by Lonza Group AG, a healthcare manufacturing company based in Switzerland. The launch of this medium resulted in a significant technological achievement by removing animal components and introducing a chemically defined formulation with regulatory-friendly attributes and application support. Furthermore, it ensures consistency, safety, and regulatory compliance in cell therapy manufacturing, thanks to its serum-free and animal component-free composition and enhanced culture and expansion capabilities. This highly aids in enhancing safety, quality, and regulatory obedience.
Access The Full Report Here:
Which Countries Are Leading the Cell Therapy Human Raw Materials Market?
North America was the largest region in the cell therapy human raw materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15759
This Report Delivers Insight On:
1. How big is the cell therapy human raw materials market, and how is it changing globally?
2. Who are the major companies in the cell therapy human raw materials market, and how are they performing?
3. What are the key opportunities and risks in the cell therapy human raw materials market right now?
4. Which products or customer segments are growing the most in the cell therapy human raw materials market?
5. What factors are helping or slowing down the growth of the cell therapy human raw materials market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
